MALVERN, PA — HMP Global’s Symposium on Advanced Wound Care (SAWC) Spring, in partnership with the Wound Healing Society (WHS) and the Wound Care Collaborative Community (WCCC), hosted the first Driving Innovation in Wound Care Summit. Held on May 13 at the Orlando World Center Marriott, this summit addressed public policy challenges related to access to wound-healing therapies.
The event took place just before the SAWC Spring | WHS meeting, which ran from May 14-18. Key stakeholders, including representatives from the Food and Drug Administration (FDA), Centers for Medicare & Medicaid Services (CMS), National Institutes of Health (NIH), clinicians, researchers, industry leaders, health systems, and payers, gathered to discuss barriers to wound care innovation. They aimed to find science-based, patient-centered solutions.
“This inaugural Driving Innovation in Wound Care Summit marks a crucial milestone in our mission,” said Vickie R. Driver, Chair of WCCC and member of the SAWC Spring Planning Committee. “It highlights the urgency and importance of our work at the WCCC to revolutionize wound care practices. Through our initiatives, we are driving transformative change in the field.”
Discussions at the summit focused on disrupting barriers to innovation with evidence, collaborations, and real-world data in FDA and payer decision-making. Participants also explored ways to define standards of care in clinical trials and practice.
“It was an honor to collaborate with the WCCC on this critical event,” said Tiffney Oliver, Vice President of the Wound Care Learning Network at HMP Global. “Initiatives like this ensure future innovation and patient-centered solutions in wound care.”
The summit’s premier supporter was Organogenesis Inc., with additional support from MIMOSA Diagnostics, Mölnlycke Health Care, MolecuLight Inc., Imbed Biosciences Inc., MediWound, Kerecis, Convatec Inc., Reapplix, MIMEDX Group, NOxy Health Products, Reprise Biomedical, Essity, and BioLab Sciences. Contributors included ARANZ Medical, Aroa Biosurgery Limited, BiogenCell LTD, GR Consulting, medaxis, Oneness Biotech, SolasCure, and Urgo Medical North America.
“Organogenesis was proud to sponsor and participate in this summit,” said Kurt Matheson, Vice President of Marketing at Organogenesis Inc. “Collaborative events and dialogue between key healthcare stakeholders are crucial for developing technologies that positively impact patients. We look forward to continued partnerships with the WCCC.”
The summit marked a significant step toward advancing wound care innovation, aiming to improve access and outcomes for patients nationwide.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.